← FDA DRUG APPROVALS

FDA ANDA · ANDA071054

CONSTILAC

Sponsor: ALRA

APPLICATION
ANDA071054
TYPE
ANDA
ORIGINAL APPROVAL
1988-07-26
LATEST ACTION
1999-11-03
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CONSTILACDiscontinued
LACTULOSE 10GM/15ML · SOLUTION · ORAL

Approval history

1999-11-03Manufacturing (CMC) · Supplement 4AP
1999-11-03Manufacturing (CMC) · Supplement 3AP
1995-06-14Manufacturing (CMC) · Supplement 2AP
1995-06-14Manufacturing (CMC) · Supplement 1AP
1988-07-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →